NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT04434560 2022-07-26Neoadjuvant Immunotherapy in Brain MetastasesDuke UniversityPhase 2 Terminated1 enrolled 7 charts